AnalysisNews

ZBH today

$104.56-$2.91 (-2.71%)close Nov 12, 2026

Trend

DailyUptrend (starting)

4 hourBearish

1 hourBearish

15 minBearish

5 minBearish

Daily trend turns down below $87.11

Key levels

Resistance$112.55

Resistance$106.20

Support$102.86

Support$99.18

Latest news & SEC filings

AnalystBarclays keeps Equal-Weight on Zimmer Biomet, lifts target to $115

AnalystLeerink Partners lifts its Zimmer Biomet target to $110 from $97

All ZBH news →

About Zimmer Biomet

Zimmer Biomet makes medical implants and related technologies for bone and joint conditions. Its offerings include replacement joints for knees and hips, products for soft tissue repair, bone healing, and chest reconstruction, along with surgical tools, bone cement, and robotic and data-driven systems. The company serves surgeons, hospitals, and other care providers, selling directly and through distributors. It operates across the Americas, Europe, the Middle East, Africa, and Asia Pacific.

Based on the company's 10-K filed Feb 20, 2026.

NYSE · Healthcare

ZIMMER BIOMET HOLDINGS, INC. (ZBH)

$104.56-2.91 (-2.71%)
WATCHLISTGrade: C+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
92.6697.03101.4105.8104.56Oct 12Oct 20Oct 28Nov 5
High108.99
Low104.24
Open108.39
Volume1.64M
Avg Vol2.13M
VWAP105.38
30d High110.15
30d Low88.29
30d Chg+18.43%

What Is the Price Target for ZBH?

SEPT Low Target

$95.00

SEPT Mid Target

$113.00

SEPT High Target

$130.00

Analyst Consensus

$113.00

Current: $107.47Upside: +5.2%Confidence: 85%Method: Analyst Consensus

Is ZBH a Buy or Sell Right Now?

53
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Critical news
Nov 4HIGHEarnings: growth/beat

Thesis

  • •Revenue growing 7.2% YoY with STABLE trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ZBH.

Start Free Trial →

Is ZBH Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/E Forward, P/B, Analyst Consensus

Fair Value

$126.14

28

Moat Score

NONE

5/9

Piotroski Score

2.6

Altman Z-Score

What Is Smart Money Doing with ZBH?

Insider Signal

NEUTRAL

0 buys / 3 sells (90d)

Congress Signal

BUYING

2 buys / 6 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
Campbell Gary CraigofficerBuy2,368-Oct 1, 2026
Campbell Gary CraigofficerSale932$82KOct 1, 2026
Campbell Gary CraigofficerBuy1,218-Oct 1, 2026
Campbell Gary CraigofficerSale480$42KOct 1, 2026
Thornal Kevin RofficerBuy9,957-Aug 1, 2026
Thornal Kevin RofficerSale4,266$395KAug 1, 2026
Yi SangofficerSale4,200$347KMay 29, 2026
Yi SangofficerSale800$66KMay 29, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

ZBH Growth Story

Revenue YoY

7.2%

3yr Revenue CAGR

5.8%

EPS Growth YoY

-19.86%

FCF Growth YoY

13.7%

Revenue Trend

STABLE

Dark Pool Trades for ZBH

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for ZBH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:23:33$104.561,430$$150KSELL
21:00:28$104.561,815$$190KSELL
21:00:28$104.562,157$$226KSELL
21:00:22$104.561,002$$105KSELL
21:00:22$104.563,057$$320KSELL

5 dark pool trades shown · $$989K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Options Flow for ZBH

PREVIEW

SEPT Investing provides real-time options flow tracking for ZBH, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

TypeStrikeExpiryDTEPremiumSizeTrade
CALL$100Nov 208$$50.3K75REGULAR

1 options trades shown · 100% calls

Unusual activity, GEX levels, max pain, and dealer positioning

See full options flow

What Traders Are Saying About ZBH

1 posts

SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for ZBH. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.

S
SEPT InvestingVERIFIED154d ago

Zone Setup -- $ZBH (ZIMMER BIOMET HOLDINGS, INC.) Price: $88.19 | Zone: $79.83 to $88.64 Conviction: HIGH | Analyst upside: +4.8% Near resistance (95% of range) — breakout watch. Positive news (2+ v...

913 views

Join 3,500+ traders discussing ZBH in real-time

Trade ideas, setups, dark pool alerts, and AI-powered analysis

Join the discussion

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for ZIMMER BIOMET HOLDINGS, INC. (ZBH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

ZBH — frequently asked questions

What is ZBH stock price today?

ZIMMER BIOMET HOLDINGS, INC. (ZBH) is at $104.56, down 2.71% (-$2.91) at the Nov 12, 2026 close.

Why is ZBH stock moving today?

Latest ZBH news — Nov 9, 2026: Barclays keeps Equal-Weight on Zimmer Biomet, lifts target to $115 · Nov 9, 2026: Leerink Partners lifts its Zimmer Biomet target to $110 from $97

What is the ZBH price target?

The average analyst price target for ZBH is $113.00, ranging from $95 to $130, based on 13 analysts. Latest: Barclays maintains on Nov 9, 2026.

What do analysts rate ZBH?

Analyst ratings for ZBH: 7 Buy, 20 Hold, 0 Sell — consensus Hold.

Did ZBH beat earnings?

ZBH last reported on Nov 4, 2026: EPS $1.00 vs $1.88 expected — a miss of 46.8%.

What is ZBH's P/E ratio?

ZBH trades at a P/E of 26.7 vs a Healthcare average of 16.8.

Does ZBH pay a dividend?

Yes. ZBH's dividend yield is 1.07%.

What are ZBH support and resistance levels?

Support: $102.86, $99.18, $94.88. Resistance: $106.20, $112.55.

What are insiders doing with ZBH?

Insider activity: NEUTRAL, 0 buys and 3 sells in the last 90 days.

What is the latest news on ZBH?

Nov 9, 2026: Barclays keeps Equal-Weight on Zimmer Biomet, lifts target to $115 · Nov 9, 2026: Leerink Partners lifts its Zimmer Biomet target to $110 from $97